Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  aminolevulinic acid hydrochloride
Find trials that include:  Any drugs shown
Results 1-7 of 7 for your search:
Start Over
Imaging Procedure Using Aminolevulinic Acid Hydrochloride in Finding Residual Tumor in Patients with Grade IV Malignant Gliomas Who Are Undergoing Surgery
Status: Active
Phase: Phase II
Type: Diagnostic
Age: 18 and over
Trial IDs: CASE 1305, NCI-2010-01385, NCT00752323
Aminolevulinic Acid in Measuring Brain Tumors in Patients With High Grade Glioma Undergoing Surgery
Status: Active
Phase: Phase II
Type: Diagnostic, Treatment
Age: 18 to 72
Trial IDs: 10101, NCI-2011-01264, NCT01116661
Aminolevulinic Acid Hydrochloride in Visualizing Tumors in Patients with Newly Diagnosed or Recurrent Malignant Gliomas Undergoing Surgery
Status: Active
Phase: Phase II
Type: Diagnostic, Treatment
Age: 18 and over
Trial IDs: WCI1999-11, NCI-2011-03426, IRB00051663, NCT01445691
Photodynamic Therapy Using Blue Light or Red Light in Treating Basal Cell Carcinoma in Patients with Basal Cell Nevus Syndrome
Status: Not yet active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: Not specified
Trial IDs: CASE 2614, NCI-2014-02037, NCT02258243
Aminolevulinic Acid Hydrochloride and Photodynamic Therapy in Preventing Actinic Keratosis and Non-melanoma Skin Cancer in Patients Who Have Undergone Solid Organ Transplant
Status: Not yet active
Phase: Phase II
Type: Prevention
Age: 18 and over
Trial IDs: PHX-16-0142-80-15, NCI-2017-00679, DUSA, NCT03110159
Quantification of ALA-induced PpIX Fluorescence in Patients with Newly Diagnosed or Recurrent Brain Tumors Undergoing Surgery
Status: Active
Phase: Phase I
Type: Diagnostic
Age: 21 and over
Trial IDs: D13066, NCI-2015-01591, STUDY00028077, NCT02191488
Photodynamic Therapy and Vismodegib in Treating Patients with Multiple Basal Cell Cancers
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 1511201549, NCI-2016-00096, ML28849, NCT02639117
Start Over